StudyGraphics #VisualAbstract: Perioperative oxiplatin with S-1 significantly improves survival in patients with advanced gastric cancer or gastroesophageal adenocarcinoma undergoing D2 gastrectomy September 23, 2021 | Teddy Guo Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print Click to read the study in The Lancet Oncology. RELATED ARTICLESMORE FROM AUTHOR #VisualAbstract Patients with advanced basal cell carcinoma who received radiation therapy are more likely to experience primary resistance to Hedgehog pathway inhibitors #VisualAbstract: Dose-escalated concurrent chemoradiotherapy does not improve survival in locally advanced esophageal cancer #VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma
